Skip to main content
Equibles

Tower Research Capital LLC (TRC)

Position in BTAIQ — BioXcel Therapeutics, Inc.

CIK 1533421 NEW YORK, NY
Back to BTAIQ Full portfolio

Position in BTAIQ

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$320
-$1,982 QoQ
Shares Held
227
-86.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 47 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BTAIQ Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $14,082,412 across 58 Drug Manufacturers - Specialty & Generic names. BTAIQ ranks #56 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HIMS
Hims & Hers Health, Inc.
 111,351 $3,860,538
2 UTHR
UNITED THERAPEUTICS Corp
 3,880 $2,102,300
3 ZTS
Zoetis Inc.
 24,069 $1,729,598
4 NBIX
Neurocrine Biosciences Inc
 7,270 $1,225,285
5 ELAN
Elanco Animal Health Inc
 38,301 $942,587
6 LNTH
Lantheus Holdings, Inc.
 6,773 $751,395
7 ALKS
Alkermes plc.
 6,157 $322,626
8 INDV
Indivior Pharmaceuticals, Inc.
 7,032 $288,522

All Filings in BTAIQ

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $320 227
2026-03-31 $2,302 1,718
2025-09-30 $10,068 3,933
2025-06-30 $2,479 1,370
2025-03-31 $308 152
2024-12-31 — 259
2024-09-30 — 10,999
2024-06-30 — 12,072
2024-03-31 — 4,627
2023-12-31 — 13,832
2023-09-30 — 4,078
2023-06-30 — 5,679
2023-03-31 — 1,529
2022-12-31 — 501
2022-09-30 — 1,250
2022-06-30 — 2,628
2022-03-31 — 3,317
2021-12-31 — 4,690
2021-09-30 — 4,686
2021-06-30 — 815
2021-03-31 — 1,716
2020-12-31 — 88
2020-09-30 — 1,770
2020-06-30 — 5,963
2020-03-31 — 119